J&J Wants Us To Ignore Falling Hep C Sales – Is That Cheating?

Olysio's flash-in-the-pan success may be unfairly and negatively skewing investors opinion of Johnson & Johnson's performance.

This podcast was recorded on Jan. 27, 2016.

Advertisement